Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

“…</p><p>Conclusions</p><p>Quantitative 3D-MRI analysis revealed significant cartilage thickness decreases after OWHTO, predominantly in the medial aspect of the PF joint. …”

BFD2 aggravates the inflammatory response to <i>Toxoplasma gondii</i> infection. by Xiaocheng Zhang (3140460)

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

“…</p><p>Conclusions</p><p>In comparison with XRT, PT can reduce most side effects, without significantly decreasing the survival rate. <b>T</b>here is considerable clinical relevance in the findings, even not all of them are statistically significant, which may facilitate the development of protocols regarding the usage of radiotherapy methods, and may encourage the establishment of more proton centers, where more studies can be done.…”

BFD2 regulates anxiety-like behaviors induced by acute-stage <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

BFD2 impacts pre-anxiety-like behaviors in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

BFD2 exacerbates the inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

BFD2 mediates brain inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

HPLC chromatogram of standard 6-gingerol (0.2 mg/mL) (a), 6-shogaol (0.2 mg/mL) (b), ginger extract obtained by conventional maceration (c), and ginger extract obtained by pulsed e... by Hataichanok Chuljerm (19144293)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Coupled gGM and CSF fMRI signal changes induced by a transient hypercapnia challenge. by Juliana Zimmermann (10507091)

Characterization of purified esAEVs based on protein content and the localization of Mif on the surface. by Safia A. Essien (20108379)

NMR aperture distribution of samples before and after 100 FTCs under three curing conditions: (a) standard curing; (b) 5 °C curing; (c) −3 °C curing. by YongHe Liu (20477123)

Sequential viral infections in adult mice beginning at 8 weeks of age stimulates a subset of immune phenotypes. by Yuhao Li (1559569)

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

“…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD_EROD,28dph of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD_length,28dph of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …”